Abstract
Magnetic resonance imaging (MRI) is a non-invasive clinical imaging modality, which has become widely used in the diagnosis of human diseases around the world. Some MRI exams include the use of contrast agents. The goal of an ideal MRI contrast agent involves the tissue- or organ-targeting materials with high relaxivity and specificity, low toxicity and side effects, suitable long intravascular duration and excretion time and high contrast enhancement with low doses, in vivo, all coupled to low overall cost. Dendrimers are synthetic, highly branched, mono-disperse macromolecules of nanometer dimensions. Properties associated with these dendrimers such as uniform size, water solubility, modifiable surface functionality and available internal cavities make them candidates for ideal carriers of MRI contrast agents. The research progress of the dendritic contrast agents is discussed.
Similar content being viewed by others
References
Lauterbur P C. Image formation by induced local interactions: Examples employing nuclear magnetic resonance. Nature, 1973, 242: 190–191
Gallez B, Swartz H M. In vivo EPR: When, how and why? NMR Biomed, 2004, 17: 223–225
Lauffer R B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: Theory and design. Chem Rev, 1987, 87: 901–927
Sener R N. Diffusion MRI findings in phenylketonuria. Eur Radiol, 2003, 13: L226–L229
Caravan P, Ellison J J, Mcmurry T J, et al. Gadolinium (III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem Rev, 1999, 99: 2293–2352
Yan G P, Zhuo R X. Research progress of magnetic resonance imaging contrast agents. Chinese Sci Bull, 2001, 46: 1233–1237
Yan G P, Robinsonand L, Hogg P. Magnetic resonance imaging contrast agents: Overview and perspectives. Radiography, 2007, 13: e5–e19
Yan G P, Peng L, Jian S Q, et al. Spin probes for electron paramagnetic resonance imaging. Chinese Sci Bull, 2008, 53: 3777–3789
Yan G P, Bischa D, Bottle S E. Synthesis and properties of novel porphyrin spin probes containing isoindoline nitroxides. Free Radic Biol Med, 2007, 43: 111–116
Platas-Iglesias C, Mato-Iglesias M, Djanashvili K, et al. Lanthanide chelates containing pyridine units with potential application as contrast agents in magnetic resonance imaging. Chem Eur J, 2004, 10: 3579–3590
Weinmann H J, Brash R C, Press W R, et al. Characteristic of gadolinium-DTPA complex: A potential NMR contrast agent. Am J Radiology, 1984, 142: 619–624
Comblin V, Gilsoul D, Hermann M, et al. Designing new MRI contrast agents: A coordination chemistry challenge. Coord Chem Rev, 1999, 185: 451–470
Wedeking P, Sotak C H, Telser J, et al. Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. Magn Reson Imaging, 1992, 10: 97–108
Mikei K, Helm L, Brucher E, et al. 17O NMR study of water exchange on Gd(DTPA)(H2O)2− and Gd(DOTA)(H2O)2− related to NMR imaging. Inorg Chem, 1993, 32: 3844–3850
Zhuo R X, Lu Z R, Wei J F, et al. The methods of synthesis of polyaminocarboxylates metal complexes. Chinese Patent, 1995, 95–1 19302.3
Lowe M P. MRI contrast agents: The next generation. Aust J Chem, 2002, 55: 551–556
Waters E A, Wickline S A. Contrast agents for MRI. Basic Res Cardiol, 2008, 103: 114–121
Yan G P, Zhang J Y, Zhou J X, et al. Targeted contrast agents for molecular imaging in magnetic resonance imaging (MRI). In: Chen X Y, ed. Recent Advances of Bioconjugate Chemistry in Molecular Imaging. Kerala, India: Research Signpost, 2008. 371–398
Wallace R A, Haar J P, Miller D B, et al. Synthesis and preliminary evaluation of MP-2269: A novel, nonaromatic small-molecule blood-pool MR contrast agent. Magn Reson Med, 1998, 40: 733–739
Duarte M G, Gil M H, Peters J A, et al. Synthesis, characterization, and relaxivity of two linear Gd(DTPA)-polymer conjugates. Bioconjugate Chem, 2001, 12: 170–177
Tóth E, Uffelen I V, Helm L, et al. Gadolinium-based linear polymer with temperature-independent proton relaxivities: A unique interplay between the water exchange and rotational contributions. Magn Reson Chem, 1998, 36: S125–S134
Mohs A M, Wang X H, Goodrich K C, et al. PEG-g-poly (DTPA-co-L-cystine): A biodegradable macromolecular blood pool contrast agent for MR imaging. Bioconjugate Chem, 2004, 15: 1424–1430
Lu Z R, Parker D L, Goodrich K C, et al. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI. Magn Reson Med, 2004, 51: 27–34
Ouyang M, Zhuo R X, Fu G C. Study on synthesis and relaxivity of paramagnetic polyester metal complexes for MRI. Ion Exchange Adsorpt, 1996, 12: 324–327
Bai Z W, Zhuo R X. The synthesis and relaxivity of polyester-amide MRI contrast agent. Ion Exchange Adsorpt, 1996, 12: 332–335
Yan G P, Zhuo R X, Zhang X, et al. Hepatic targeting macromolecular MRI contrast agents. Polym Int, 2002, 51: 892–898
Brasch R C. Rationable and applications for macromolecular Gd-based contrast agents. Magn Reson Med, 1991, 22: 282–287
Aime S, Botta M, Crich S G, et al. Towards MRI contrast agent of improved efficacy NMR relaxometric investigations of the binding interaction HSA of a novel heptadentate macrocyclic triphosphonate Gd3+-complex. J Biol Inorg Chem, 1997, 2: 470–479
Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, et al. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest Radiol, 1991, 26: 969–974
Roberts H C, Saeed M, Roberts T P L, et al. MRI of acute myocardial ischemia: Comparing a new contrast agent, Gd-dtpa-24-cascade-polymer, with Gd-dtpa. J Magn Reson Imaging, 1999, 9: 204–208
Judd R M, Reeder S B, May-Newman K. Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents. Magn Reson Med, 1999, 41: 334–342
Wen X X, Jackson E F, Price R E, et al. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: A new biodegradable MRI contrast agent. Bioconjugate Chem, 2004, 15: 1408–1415
Lu Z R, Wang X H, Parker D L, et al. Poly(L-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging. Bioconjugate Chem, 2003, 14: 715–719
Uzgiris E E, Cline H, Moasser B, et al. Conformation and structure of polymeric contrast agents for medical imaging. Biomacromolecules, 2004, 5: 54–61
Yan G P, Wang X Y, Wang X L, et al. Synthesis and in vitro property study of polyaspartamides. Chin J Chem, 2007, 25: 1748–1753
Yan G P, Zhuo R X, Xu M Y, et al. Liver-targeting Macromolecular MRI Contrast Agents. Sci China Ser B-Chem, 2001, 44: 344–352
Waeckerle-Mena Y, Groettrupa M. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines. Adv Drug Deliv Rev, 2005, 57: 475–482
Tansey W, Ke S, Cao X Y, et al. Synthesis and characterization of branched poly(L-glutamic acid) as a biodegradable drug carrier. J Control Release, 2004, 94: 39–51
Patri A K, Majoros I J, Baker J R. Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol, 2002, 6: 466–471
Bezouska K. Design, functional evaluation and biomedical applications of carbohydrate dendrimers glycodendrimers. Rev Mol Biotechnol, 2002, 90: 269–290
Choia J S, Namb K, Parkb J Y, et al. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release, 2004, 99: 445–456
Namazi H, Adeli M. Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. Biomaterials, 2005, 26: 1175–1183
Devarakonda B, Hill R A, de Villiers M M. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm, 2004, 284: 133–140
Metullio L, Ferrone M, Coslanich A, et al. Polyamidoamine (yet not PAMAM) dendrimers as bioinspired materials for drug delivery: Structure-activity relationships by molecular simulations. Biomacromolecules, 2004, 5: 1371–1378
Zhou J H, Wu J Y, Hafdi N, et al. PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun, 2006: 2362–2364
Sanchez-Sancho F, Perez-Inestrosa E, Suau R, et al. Dendrimers as carrier protein mimetics for IgE antibody recognition: Synthesis and characterization of densely penicilloylated dendrimers. Bioconjugate Chem, 2002, 13: 647–653
Allen M J, Raines R T, Kiessling L L. Contrast agents for mgnetic resonance imaging synthesized with ring-opening metathesis polymerization. J Am Chem Soc, 2006, 128: 6534–6535
Neerman M F, Zhang W, Parrish A R, et al. In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery. Int J Pharm, 2004, 281: 129–132
Beezer A E, King A S H, Martin K, et al. Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives. Tetrahedron, 2003, 59: 3873–3880
Vandamme T F, Brobeck L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release, 2005, 102: 23–38
Schatzleina A G, Zinselmeyera B H, Dufesa A C, et al. Preferential liver gene expression with polypropylenimine dendrimers. J Control Release, 2005, 101: 247–258
Balogh L, de Leuze-Jallouli A, Dvornic P, et al. Architectural copolymers of PAMAM dendrimers and ionic polyacetylenes. Macromolecules, 1999, 32: 1036–1042
Hudson S D, Jung H T, Percec V, et al. Direct visualization of individual cylindrical and spherical supramolecular dendrimers. Science, 1997, 278: 449–452
Kleinman M H, Flory J H, Tomalia D A, et al. Effect of protonation and PAMAM dendrimer size on the complexation and dynamic mobility of 2-naphthol. J Phys Chem B, 2000, 104: 11472–11479
Nicolle G M, Toth E, Schmitt-Willich H, et al. The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent. Chem Eur J, 2002, 8: 1040–1048
Stiriba S E, Frey H, Haag R. Dendritic polymers in biomedical applications: From potential to clinical use in diagnostics and therapy. Angew Chem Int Ed, 2002, 41: 1329–1334
Esfand R, Tomalia D A. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today, 2001, 6: 427–436
Kobayshi H, Kawamoto S, Jo S K, et al. Macromolecular MRI contrast agents with small dendrimers: Pharmacokinetic differences between sizes and cores. Bioconjugate Chem, 2003, 14: 388–394
Margerum L D, Campion B K, Koo M, et al. Gadolinium (III) DO3A macrocycles and polyethylene glycol coupled to dendriers effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents. J Alloy Comp, 1997, 249: 185–190
Fischer M, Vögtle F. Dendrimers: From design to application—A progress report. Angew Chem Int Ed, 1999, 38: 884–905
Wiener E C, Brechbiel M W, Brothers H, et al. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn Reson Med, 1994, 31: 1–8
Kobayashi H, Jo S K, Kawamoto S, et al. Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure. J Magn Reson Imaging, 2004, 20: 512–518
Kobayashi H, Kawamoto S, Saga T, et al. Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents. Magn Reson Med, 2001, 46: 781–788
Wiener E C, Auteri F P, Chen J W, et al. Molecular dynamics of Ion-chelate complexes attached to dendrimers. J Am Chem Soc, 1996, 118: 7774–7782
Bryant L H, Brechbiel M W, Wu C C, et al. Synthesis and relaxometry of high-generation (G=5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J Magn Reson Imaging, 1999, 9: 348–352
Langereis S, de Lussanet Q G, van Genderen M H P, et al. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. NMR Biomed, 2006, 19: 133–141
Canetta E, Maino G. Molecular dynamic analysis of the structure of dendrimers. Nucl Instrum Meth Phys Res B, 2004, 213: 71–74
Kobayashi H, Brechbiel M W. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev, 2005, 57: 2271–2286
Kobayashi H, Kawamoto S, Star R A, et al. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res, 2003, 63: 271–276
Kobayashi H, Kawamoto S, Choyke P L, et al. Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med, 2003, 50: 758–766
Francese G, Dunand F A, Loosli C, et al. Functionalization of PAMAM dendrimers with nitronyl nitroxide radicals as models for the outer-sphere relaxation in dentritic potential MRI contrast agents. Magn Reson Chem, 2003, 41: 81–83
Winalski C S, Shortkroff S, Mulkern R V, et al. Magnetic resonance relaxivity of dendrimer-linked nitroxides. Magn Reson Med, 2002, 48: 965–972
Strable E, Bulte J W M, Moskowitz B, et al. Synthesis and characterization of soluble iron oxide-dendrimer composites. Chem Mater, 2001, 13: 2201–2209
Yan G P, Liu M L, Li L Y. Studies on polyaspartamide gadolinium complexes containing sulfadiazine groups as MRI contrast agents. Bioconjugate Chem, 2005, 16: 967–971
Yan G P, Liu M L, Li L Y. Studies on polyaspartamide gadolinium complexes as potential magnetic resonance imaging contrast agents. Radiography, 2005, 11: 117–122
Yan G P, Zheng C Y, Cao W, et al. Synthesis and preliminary evaluation of gadolinium complexes containing sulfonamide groups as potential MRI contrast agents. Radiography, 2003, 9: 35–41
Yan G P, Zhuo R X, Yang Y H, et al. Tumor-selective macromolecular MRI contrast agents. J Bioact Compat Polym, 2002, 17: 139–151
Sega E I, Low P S. Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev, 2008, 27: 655–664
Wiener E C, Konda S, Shadron A, et al. Targeting dendrimer-chelates to tumours and tumour cells expressing the high-affinity folate receptor. Invest Radiol, 1997, 32: 748–754
Konda S D, Aai]ref M, Wang S, et al. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magnetic Resonance Materials in Physics. Biol Med, 2001, 12: 104–113
Sun C, Sze R, Zhang M Q. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A, 2006, 78A: 550–557
Kobayashi H, Kawamoto S, Saga T, et al. Avidin-dendrimer-(1B4M-Gd)254: A tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI. Bioconjugate Chem, 2001, 12: 587–593
Yan G P, Hu B, Liu M L, et al. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents. J Pharm Pharmacol, 2005, 57: 351–357
Du B, Zhou R J, Zhou R X. Synthesis of cyclic core dendritic polymer and its usage as a vector for transferring foreign DNA into human cells. Chin Chem Lett, 1998, 9: 635–638
Yan G P, Bottle S E, Zhuo R X, et al. Evaluation on dendritic gadolinium complexes as MRI contrast agents. J Bioact Compatible Polym, 2004, 19: 453–465
Langereis S, Dirksen A, Hackeng T M, et al. Dendrimers and magnetic resonance imaging. New J Chem, 2007, 31: 1152–1160
Lu Z R, Ye F R, Vaidya A. Polymer platforms for drug delivery and biomedical imaging. J Control Release, 2007, 122: 269–277
Kim J H, Park K, Nam H Y, et al. Polymers for bioimaging. Prog Polym Sci, 2007, 32: 1031–1053
Lee L J, Park K, Lee S, et al. New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv Funct Mater, 2009, 19: 1553–1566
Mulder A, Huskens J, Reinhoudt D N. Multivalency in supramolecular chemistry and nanofabrication. Org Biomol Chem, 2004, 2: 3409–3424
Badjic J D, Nelson A, Cantrill S J, et al. Multivalency and cooperativity in supramolecular chemistry. Ace Chem Res, 2005, 38: 723–732
Koyama Y, Talanov V S, Bernardo M, et al. A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging, 2007, 25: 866–871
Dirksen A, Langereis S, de Waal B F M, et al. A supramolecular approach to multivalent target-specific MRI contrast agents for angiogenesis. Chem Commun, 2005: 2811–2813
Liu J Y, Zheng Y F. Development of magnetic resonance imaging contrast agents with PAMAM dendrimer cores. Mater Rev, 2007, 5: 69–72
Talanov V S, Regin O C A, Kobayashi H, et al. Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett, 2006, 6: 1459–1463
Wu P, Malkoch M, Hunt J N, et al. Multivalent, bifunctional dendrimers prepared by click chemistry. Chem Commun, 2005: 5775–5777
Lee C C, MacKay J A, Frechet J M, et al. Designing dendrimers for biological applications. Nat Biotechnol, 2005, 23: 1517–1526
Bai J F, Gu W, Ye L. The potential application of dendrimers in medicine. Chemistry, 2001, 64: W119
Sadler K, Tam J P. Peptide dendrimers: Applications and synthesis. Rev Mol Biotechnol, 2002, 90: 157–354
Turnbull W B, Stoddart J F. Design and synthesis of glycodendrimers. Rev Mol Biotechnol, 2002, 90: 231–255
Dirksen A, Meijer E W, Adriaens W, et al. Strategy for the synthesis of multivalent peptide-based nonsymmetric dendrimers by native chemical ligation. Chem Commun, 2006, 1667–1669
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yan, G., Ai, C., Li, L. et al. Dendrimers as carriers for contrast agents in magnetic resonance imaging. Chin. Sci. Bull. 55, 3085–3093 (2010). https://doi.org/10.1007/s11434-010-3267-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-010-3267-4